Medicamento para perda de peso da Novo Nordisk reduz risco cardiovascular em não diabéticos

S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Medicamento para perda de peso da Novo Nordisk reduz risco cardiovascular em não diabéticos

/jornal/2023/11/medicamento-para-perda-de-peso-da-novo-nordisk-reduz-risco-cardiovascular-em-nao-diabeticos/

Novo Nordisk (BOV:N1VO34)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Novo Nordisk Charts.

Novo Nordisk (BOV:N1VO34)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Novo Nordisk Charts.

News

Real-Time news about Novo Nordisk (Brazil Bovespa Exchange): 0 recent articles

More News Articles

S&P ASX 300 Metals and M...

Commonwealth Bank Of Aus...

Australia And New Zealan...

AUD vs US Dollar

National Australia Bank

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions